Mereo BioPharma Key Ratios (2017-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Profitability
Gross Margin (Quarter)								61.89%		127.30%						80.00%
EBT Margin (Quarter)								-19.46%		-964.10%						-2,923.20%
EBIT Margin (Quarter)								-9.01%		-712.80%						-2,099.80%
EBITDA Margin (Quarter)								-9.01%		-712.80%						-2,099.80%
Operating Margin (Quarter)								-9.01%		-712.80%						-2,099.80%
Net Margin (Quarter)										-910.90%						-2,923.20%
FCF Margin (Quarter)										-678.90%						-1,530.20%
Efficiency
Assets Average (Quarter)	123.73M										61.22M	76.03M	92.44M	82.57M	72.36M	65.48M	58.12M	49.76M	43.27M	37.66M
Invested Capital (Quarter)	34.47M	21.31M		19.39M	20.09M	13.00M		9.82M
Asset Utilization Ratio (Quarter)											0.16	0.01	0.01			0.01	0.01	0.01		0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)							-14.26	-0.79	-12.95	-16.13	-31.94	-0.68	-0.39	-32.50	-58.34	-1.04	-2.07	-364.78	-42.55	-6.54
Debt Ratio (Quarter)	0.25
Times Interest Earned (Quarter)							-14.26	-0.79	-12.95	-16.13	-31.94	-0.68	-0.39	-32.50	-58.34	-1.04	-2.07	-364.78	-42.55	-6.54
Valuation
Enterprise Value (Quarter)	-70.55M	-30.99M	-153.88M	-127.11M	-96.23M	-66.08M		-52.70M		-57.42M	-48.70M	-87.43M	-80.52M	-69.80M	-62.50M	-56.12M	-48.70M	-40.99M	-36.22M	-30.12M
Return Ratios
Return on Sales (Quarter)										-0.09%	-0.02%	-0.37%	-0.45%			-0.29%	-1.05%	-1.05%		-0.77%
Return on Capital Employed (Quarter)											-53.58%	-64.24%	-50.13%	-68.92%	-75.03%	-80.02%	-90.19%	-88.23%	-101.57%	-106.92%
Return on Invested Capital (Quarter)										-0.02%	-0.03%
Return on Assets (Quarter)											0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%

Mereo BioPharma MREO Ratios (2017-2026)